Influence of Nanomedicine as a Smart Weapon for Multidrug Resistance in Cancer Therapy

Area of Science:

• Oncology and Nanomedicine

Background:

• Multidrug resistance (MDR) significantly limits chemotherapy effectiveness in cancer patients.
• ATP-binding Cassette (ABC) transporters contribute to MDR by increasing drug efflux and reducing intracellular drug accumulation.

Purpose of the Study:

• To review the application of nanomaterials in cancer therapy.
• To highlight the role of nanotechnology in overcoming MDR.
• To discuss challenges in translating nanomedicine to clinical practice.

Main Methods:

• Literature review of nanotechnology-based cancer treatment strategies.
• Analysis of nanomaterial design for targeting cancer cells and the tumor microenvironment.
• Examination of mechanisms by which nanoparticles address MDR.

Main Results:

• Nanomaterials show promise in improving drug bioavailability and reducing toxicity in cancer therapy.
• Nanoparticle-based systems can enhance the efficacy of chemotherapeutic drugs by overcoming MDR.
• Targeted delivery by nanomaterials improves therapeutic outcomes.

Conclusions:

• Nanomaterials represent a promising approach to enhance cancer chemotherapy and combat MDR.
• Further research is needed to address obstacles hindering the clinical translation of nanomedicine.
• Nanotechnology holds potential for developing more effective and safer cancer treatments.